Identification of a novel homozygous mutation in NAXE gene associated with early-onset progressive encephalopathy by whole-exome sequencing: in silico protein structure characterization, molecular docking, and dynamic simulation.


Journal

Neurogenetics
ISSN: 1364-6753
Titre abrégé: Neurogenetics
Pays: United States
ID NLM: 9709714

Informations de publication

Date de publication:
10 2022
Historique:
received: 03 05 2022
accepted: 04 07 2022
pubmed: 13 7 2022
medline: 18 11 2022
entrez: 12 7 2022
Statut: ppublish

Résumé

Progressive encephalopathy with brain edema and/or leukoencephalopathy, PEBEL1, is a severe neurometabolic disorder characterized by rapidly progressive neurologic deterioration associated with a febrile illness. PEBEL1 is a lethal encephalopathy caused by NAXE gene mutations. Here we report a 6-month-old boy with mitochondrial encephalomyopathy from a consanguineous family. Molecular analysis was performed using whole-exome sequencing followed by segregation analysis. In addition, in silico prediction tools and molecular dynamic approaches were used to predict the structural effect of the mutation. Furthermore, molecular docking of the substrate NADP in both wild-type and mutated NAXE protein was carried out. Molecular analysis revealed the presence of the novel homozygous mutation c.641 T > A (p. Ile214Asn) in the NAXE gene, located at the NAD (P)H hydrate epimerase domain. In addition, bioinformatics analyses and molecular dynamics revealed that p. Ile214Asn mutation could affect the structure, stability, and compactness of the NAXE protein. Moreover, the result of the molecular docking showed that the p. Ile214Asn mutation leads to conformational changes in the catalytic cavity, thus modifying interaction with the substrate and restricting its access. We also compared the phenotype of our patient with those of previously reported cases with PEBEL syndrome. All bioinformatics findings provide evidence that the NAXE variant Asn214 disrupts NAXE protein functionality leading to an insufficient NAD (P)HX repair system and the development of clinical features of PEBEL1 syndrome in our patient. To our knowledge, our case is the 21st case of PEBEL1 patient worldwide and the first case in North Africa.

Identifiants

pubmed: 35819538
doi: 10.1007/s10048-022-00696-3
pii: 10.1007/s10048-022-00696-3
doi:

Substances chimiques

NAD 0U46U6E8UK
NAXE protein, human EC 5.1.-
Racemases and Epimerases EC 5.1.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

257-270

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Colinas M, Shaw HV, Loubéry S et al (2014) A pathway for repair of NAD(P)H in plants. J Biol Chem 289:14692–14706. https://doi.org/10.1074/jbc.M114.556092
doi: 10.1074/jbc.M114.556092 pubmed: 24706747 pmcid: 4031525
Becker-Kettern J, Paczia N, Conrotte J-F et al (2018) NAD(P)HX repair deficiency causes central metabolic perturbations in yeast and human cells. FEBS J 285:3376–3401. https://doi.org/10.1111/febs.14631
doi: 10.1111/febs.14631 pubmed: 30098110
Kremer LS, Danhauser K, Herebian D et al (2016) NAXE mutations disrupt the cellular NAD(P)HX repair system and cause a lethal neurometabolic disorder of early childhood. Am J Hum Genet 99:894–902. https://doi.org/10.1016/j.ajhg.2016.07.018
doi: 10.1016/j.ajhg.2016.07.018 pubmed: 27616477 pmcid: 5065653
Trinh J, Imhoff S, Dulovic-Mahlow M et al (2020) Novel NAXE variants as a cause for neurometabolic disorder: implications for treatment. J Neurol 267:770–782. https://doi.org/10.1007/s00415-019-09640-2
doi: 10.1007/s00415-019-09640-2 pubmed: 31745726
Linster CL, Van Schaftingen E, Hanson AD (2013) Metabolite damage and its repair or pre-emption. Nat Chem Biol 9:72–80. https://doi.org/10.1038/nchembio.1141
doi: 10.1038/nchembio.1141 pubmed: 23334546
Marbaix AY, Noël G, Detroux AM et al (2011) Extremely conserved ATP- or ADP-dependent enzymatic system for nicotinamide nucleotide repair. J Biol Chem 286:41246–41252. https://doi.org/10.1074/jbc.C111.310847
doi: 10.1074/jbc.C111.310847 pubmed: 21994945 pmcid: 3308837
Fang L, Choi S-H, Baek JS et al (2013) Control of angiogenesis by AIBP-mediated cholesterol efflux. Nature 498:118–122. https://doi.org/10.1038/nature12166
doi: 10.1038/nature12166 pubmed: 23719382 pmcid: 3760669
Ritter M, Buechler C, Boettcher A et al (2002) Cloning and characterization of a novel apolipoprotein A-I binding protein, AI-BP, secreted by cells of the kidney proximal tubules in response to HDL or ApoA-I. Genomics 79:693–702. https://doi.org/10.1006/geno.2002.6761
doi: 10.1006/geno.2002.6761 pubmed: 11991719
Spiegel R, Shaag A, Shalev S, Elpeleg O (2016) Homozygous mutation in the APOA1BP is associated with a lethal infantile leukoencephalopathy. Neurogenetics 17.  https://doi.org/10.1007/s10048-016-0483-3
Incecık F, Ceylaner S (2020) Early-onset progressive encephalopathy associated with NAXE gene variants: a case report of a Turkish child. Acta Neurol Belg 120:733–735. https://doi.org/10.1007/s13760-019-01242-z
doi: 10.1007/s13760-019-01242-z pubmed: 31758406
Yu D, Zhao F-M, Cai X-T, et al (2018) Clinical and genetic features of early-onset progressive encephalopathy associated with NAXE gene mutations. Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 20:524–258. https://doi.org/10.7499/j.issn.1008-8830.2018.07.002
Mohammadi P, Heidari M, Ashrafi MR et al (2021) A novel homozygous missense variant in the NAXE gene in an Iranian family with progressive encephalopathy with brain edema and leukoencephalopathy. Acta Neurol Belg. https://doi.org/10.1007/s13760-021-01717-y
doi: 10.1007/s13760-021-01717-y pubmed: 34152582
Lewin HA, Stewart-Haynes JA (1992) A simple method for DNA extraction from leukocytes for use in PCR. Biotechniques 13:522–524
pubmed: 1476717
Venegas V, Wang J, Dimmock D, Wong L-J (2011) Real-time quantitative PCR analysis of mitochondrial DNA content. Curr Protoc Hum Genet Chapter 19:Unit 19.7. https://doi.org/10.1002/0471142905.hg1907s68
Rieder MJ, Taylor SL, Tobe VO, Nickerson DA (1998) Automating the identification of DNA variations using quality-based fluorescence re-sequencing: analysis of the human mitochondrial genome. Nucleic Acids Res 26:967–973. https://doi.org/10.1093/nar/26.4.967
doi: 10.1093/nar/26.4.967 pubmed: 9461455 pmcid: 147367
Ferrer-Costa C, Gelpí JL, Zamakola L et al (2005) PMUT: a web-based tool for the annotation of pathological mutations on proteins. Bioinformatics 21:3176–3178. https://doi.org/10.1093/bioinformatics/bti486
doi: 10.1093/bioinformatics/bti486 pubmed: 15879453
Schwarz JM, Cooper DN, Schuelke M, Seelow D (2014) MutationTaster2: mutation prediction for the deep-sequencing age. Nat Methods 11:361–362. https://doi.org/10.1038/nmeth.2890
doi: 10.1038/nmeth.2890 pubmed: 24681721
Bendl J, Stourac J, Salanda O et al (2014) PredictSNP: robust and accurate consensus classifier for prediction of disease-related mutations. PLoS Comput Biol 10:e1003440. https://doi.org/10.1371/journal.pcbi.1003440
doi: 10.1371/journal.pcbi.1003440 pubmed: 24453961 pmcid: 3894168
Capriotti E, Fariselli P, Casadio R (2005) I-Mutant2.0: predicting stability changes upon mutation from the protein sequence or structure. Nucleic Acids Res 33:W306-310. https://doi.org/10.1093/nar/gki375
doi: 10.1093/nar/gki375 pubmed: 15980478 pmcid: 1160136
Trott O, Olson AJ (2010) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31:455–461. https://doi.org/10.1002/jcc.21334
doi: 10.1002/jcc.21334 pubmed: 19499576 pmcid: 3041641
Fereidoonnezhad M, Mostoufi A, Eskandari M et al (2018) Multitarget drug design, molecular docking and PLIF studies of novel tacrine-coumarin hybrids for the treatment of Alzheimer’s disease. Iran J Pharm Res 17:1217–1228
pubmed: 30568682 pmcid: 6269558
Prabhakar P, Laboy JI, Wang J et al (1998) Effect of NADH-X on cytosolic glycerol-3-phosphate dehydrogenase. Arch Biochem Biophys 360:195–205. https://doi.org/10.1006/abbi.1998.0939
doi: 10.1006/abbi.1998.0939 pubmed: 9851831
Marbaix AY, Tyteca D, Niehaus TD et al (2014) Occurrence and subcellular distribution of the NADPHX repair system in mammals. Biochem J 460:49–58. https://doi.org/10.1042/BJ20131482
doi: 10.1042/BJ20131482 pubmed: 24611804
Bogunia M, Makowski M (2020) Influence of ionic strength on hydrophobic interactions in water: dependence on solute size and shape. J Phys Chem B 124:10326–10336. https://doi.org/10.1021/acs.jpcb.0c06399
doi: 10.1021/acs.jpcb.0c06399 pubmed: 33147018 pmcid: 7681779
Childers MC, Daggett V (2017) Insights from molecular dynamics simulations for computational protein design. Mol Syst Des Eng 2:9–33. https://doi.org/10.1039/C6ME00083E
doi: 10.1039/C6ME00083E pubmed: 28239489 pmcid: 5321087
Jha KN, Shumilin IA, Digilio LC et al (2008) Biochemical and structural characterization of apolipoprotein A-I binding protein, a novel phosphoprotein with a potential role in sperm capacitation. Endocrinology 149:2108–2120. https://doi.org/10.1210/en.2007-0582
doi: 10.1210/en.2007-0582 pubmed: 18202122 pmcid: 2329272
Rayevsky A, Sirokha D, Samofalova D et al (2021) Functional effects in silico prediction for androgen receptor ligand-binding domain novel I836S mutation. Life (Basel) 11:659. https://doi.org/10.3390/life11070659
doi: 10.3390/life11070659
Alila-Fersi O, Aloulou H, Werteni I et al (2020) Mutations in GAA Gene in Tunisian families with infantile onset Pompe disease: novel mutation and structural modeling investigations. J Mol Neurosci 70:1100–1109. https://doi.org/10.1007/s12031-020-01516-9
doi: 10.1007/s12031-020-01516-9 pubmed: 32125626
Arenas-Jal M, Suñé-Negre JM, García-Montoya E (2020) Therapeutic potential of nicotinamide adenine dinucleotide (NAD). Eur J Pharmacol 879:173158. https://doi.org/10.1016/j.ejphar.2020.173158
doi: 10.1016/j.ejphar.2020.173158 pubmed: 32360833
Lw C, Ss L, Ch C, et al (2021) NAXE gene mutation-related progressive encephalopathy: A case report and literature review. Medicine 100.  https://doi.org/10.1097/MD.0000000000027548

Auteurs

Marwa Maalej (M)

Molecular Genetics and Functional Laboratory, Faculty of Science of Sfax, University of Sfax, Sfax, Tunisia. marwamaalej7@gmail.com.

Lamia Sfaihi (L)

Department of Pediatrics, Hédi Chaker Hospital, 3029, Sfax, Tunisia.
Faculty of Medecine of Sfax, Avenue Magida Boulila, 3029, Sfax, Tunisia.

Marwa Ammar (M)

Molecular Genetics and Functional Laboratory, Faculty of Science of Sfax, University of Sfax, Sfax, Tunisia.

Fakher Frikha (F)

Laboratory of Molecular and Cellular Screening Processes (LPCMC), LR15CBS07, Center of Biotechnology of Sfax, University of Sfax, Sfax, Tunisia.

Marwa Kharrat (M)

Molecular Genetics and Functional Laboratory, Faculty of Science of Sfax, University of Sfax, Sfax, Tunisia.

Olfa Alila-Fersi (O)

Molecular Genetics and Functional Laboratory, Faculty of Science of Sfax, University of Sfax, Sfax, Tunisia.

Emna Mkaouar-Rebai (E)

Molecular Genetics and Functional Laboratory, Faculty of Science of Sfax, University of Sfax, Sfax, Tunisia.

Abdelaziz Tlili (A)

Department of Applied Biology, College of Sciences, University of Sharjah, Sharjah, United Arab Emirates.

Thouraya Kammoun (T)

Department of Pediatrics, Hédi Chaker Hospital, 3029, Sfax, Tunisia.
Faculty of Medecine of Sfax, Avenue Magida Boulila, 3029, Sfax, Tunisia.

Faiza Fakhfakh (F)

Molecular Genetics and Functional Laboratory, Faculty of Science of Sfax, University of Sfax, Sfax, Tunisia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH